Clinical User Experience with MVision AI

This is a webinar that you don’t want to miss! You’ll hear from an actual user and their clinical experience with MVision’s AI-powered software. Please join us as our guest speaker, Ryan Schurr from UMC in Lubbock, Texas, presents his experience with MVision AI and how MVision enhanced UMC’s auto-contouring success and statistics. Mr. Schurr will also speak about the positive impact MVision had on UMC’s planning timeline, and wrap up with products in development. Discover how MVision AI’s cutting-edge solutions can help you to increase the overall quality and reliability of patient treatment plans while significantly reducing manual work time.

At MVision AI, we believe that AI has the potential to transform radiotherapy and empower clinicians to make better decisions. By integrating seamlessly into existing clinical workflows, our AI-powered solutions provide clinicians with valuable insights that enable faster, more accurate and more streamlined radiotherapy treatment planning. Don’t miss this exciting opportunity to learn from a user and discover for yourself how MVision AI’s HIPAA-compliant, high-quality solutions can help you to gain more contouring confidence and ultimately provide better care for your patients.

Our Newsletter

Subscribe to get information, latest news and other interesting offers about MVision AI

Related Posts

13.12.2024

Saad Ullah Akram Appointed as CEO of MVision AI

Helsinki, Finland – MVision AI, a leading provider of AI-powered solutions for radiation therapy treatment planning, announces the appointment of Saad Ullah Akram as its new Chief Executive Officer. Known for its commitment to streamlining workflows and enhancing treatment quality in cancer care, MVision AI is embarking on an exciting…

Press Releases

20.11.2024

MVision AI Ranked Among the Top 10 in Deloitte Technology Fast 50 Finland for 2024

Helsinki, Finland, 20 November 2024 – MVision AI, a leading innovator in AI-driven solutions for oncology, is proud to announce its recognition among the top ten companies in the Deloitte Technology Fast 50 Finland 2024 ranking. This prestigious award acknowledges MVision AI's rapid growth and its mission-driven advancements in making…

Press Releases

7.11.2024

Safe and Ethical AI in Radiation Oncology: Regulations and MVision’s Compliance

Technology is evolving, and the same applies to Radiation Oncology. New ways and new tools require new rules. Artificial intelligence (AI)  brings tremendous potential, so the world has to learn how to get the best of it, safely.  Al systems identified as high-risk have to comply with strict requirements, including…

Articles